The proposed approach responds to an increasingly diverse research landscape. Cambridge Dictionary defines botany as “the scientific study of plants,” while Treccani describes it as the branch of biology that studies plant organisms. Contemporary plant research, however, includes basic and applied studies of plant uses and extracts, including work in agronomy and medicine that may be described as “applied botany.”

Botany’s disciplinary history is also closely connected with its use and development. The word “botany” was coined by Homer in The Iliad in the eighth century BC, according to the article. Botany became an independent science from medicine during the Renaissance, while the cultivation of plants for food and aesthetic purposes dates back at least 11,700 years. These overlapping histories complicate any attempt to assign plant-related work to one field.

The article cites signs of institutional change in academic botany. Pure botany is reportedly taught less frequently, basic research has become rarer because of funding limitations, and applied research has attracted greater financial support. Some scholars have described these developments as a claim for “the end of botany,” while others report that foundational subjects such as nomenclature are receiving less attention. At the same time, “botany” and “botanist” are increasingly being replaced in academia by “plant biology” and “plant biologist.”

Outside universities, the terminology is used more broadly, sometimes for anyone working with plants for any purpose. Agronomists, arboriculturists, gardeners, herbalists, phytotherapists and plant pharmacologists may all fall under the informal label. The article argues that this broad usage can obscure professional distinctions and lead members of the public to seek advice from people whose training may not include a strong foundation in botany. Botanical gardens face a related perception problem, as their scientific functions may be mistaken for those of ornamental gardens or parks.

To represent the overlap among botany, agronomy and medicine, the article uses a ternary plot, a barycentric diagram in which three variables sum to a constant and their relative proportions are represented as positions within an equilateral triangle. Specialized research areas occupy overlapping positions rather than fitting neatly into one discipline. The author identifies a “Triangle of Botany,” defined as the area in which basic plant science remains the predominant component.

Under the proposed definitions, a botanist is a professional or scientist whose primary research focus is basic research on plant organisms or research applied to nature conservation. A botanical garden is a space dedicated to cultivating, conserving, studying and displaying plants, based primarily on scientific principles grounded in basic research, conservation research or both. This emphasis on documented living collections, scientific research, conservation, display and education broadly accords with the definition used by Botanic Gardens Conservation International.

The framework has several stated implications. Researchers focused mainly on the uses of plants rather than plants themselves would be classified as agronomists or medical researchers rather than botanists. A facility displaying and documenting only crops would be a crop collection field rather than a botanic garden, while one devoted only to ornamental plants would be a garden or park. In wider society, the proposed test is whether expertise concerns plants themselves or their uses, with the latter associated with agricultural, horticultural, herbal and pharmacological professions.

The article also distinguishes interdisciplinary, multidisciplinary and transdisciplinary approaches. Interdisciplinarity integrates multiple disciplines into one research activity, whereas multidisciplinarity studies a topic through several disciplinary perspectives at once; both remain within disciplinary research. Transdisciplinarity extends beyond and integrates disciplines, represented in the framework by a central region in which no single discipline dominates. Under this classification, phytochemistry, plant biotechnology and the biology of agronomic and forest plants retain a predominant botanical component, whereas transdisciplinary work includes topics such as alimurgical plants and aerobiology. Research dominated by agronomic or medical components is characterized as interdisciplinary or multidisciplinary agronomic or medical research rather than applied botany. The contribution is a proposed conceptual classification, supported by illustrative examples rather than an empirical evaluation of how consistently practitioners or institutions meet its definitions.

Subject of Research: A conceptual framework for defining botany, botanists and botanical gardens

Article Title: Some claim for the end of Botany… but what is Botany today?

Article References: Peruzzi, L. (2025). Some claim for the end of Botany… but what is Botany today?. Italian Botanist, 19, 15-20. https://doi.org/10.3897/italianbotanist.19.145382

Image Credits: AI Generated

DOI: 10.3897/italianbotanist.19.145382

Keywords: botany, plant science, botanical gardens, agronomy, basic research, conservation, interdisciplinarity, discipline boundaries, plant nomenclature, Some, claim, today

The new studies, published in the journal Molecular Cell, come from the Institute of Biochemistry at ETH Zurich, led by professors Ulrike Kutay, Karsten Weis and Madhav Jagannathan, together with colleagues from the University of Fribourg, the Paul Scherrer Institute, the European Molecular Biology Laboratory and RWTH Aachen University. Their work demonstrates for the first time that two molecular tools are required for the two membranes of the nuclear envelope to fuse correctly: an enzyme called Torsin-1A and a complex built from multiple copies of a protein known as CLCC1 in human cells. In fungi, the same job is carried out by the related proteins Brl1 and Brr6, a detail that underscores how deeply conserved this fusion machinery is across the tree of life, from yeast to flies to mammals.

Until now, scientists knew that a defect in Torsin-1A brings nuclear pore assembly to a halt, with fatal consequences for the cell, but the mechanics of the partnership remained obscure. The ETH-led teams have now shown how the cooperation works at a molecular level. Torsin-1A binds to CLCC1 and helps several of these building blocks join together into a larger assembly. Once the complex is formed, Torsin-1A escorts it to the site of pore assembly on the nuclear envelope, positioning it exactly where the two membranes must merge. In other words, the enzyme acts both as a chaperone that assembles the fusion machinery and as a guide that delivers it to its workplace.

The fusion mechanism itself caught the researchers off guard. Using computer simulations, the teams hypothesised that CLCC1 proteins, or their fungal relatives Brl1 and Brr6, forge a temporary channel inside the nuclear envelope. This channel allows lipid molecules to flow across the bilayers, a movement that is normally restricted. The resulting lipid exchange destabilises the local membrane structure and forces the inner and outer nuclear membranes to fuse with one another. Daria Maslennikova, the first author of one of the studies, who completed her doctorate in Kutay’s group, said the teams had not expected such a mechanism. The idea that a protein complex could catalyse membrane merger by opening a lipid conduit, rather than by directly pulling the membranes together, adds a striking new entry to the catalogue of ways cells remodel their internal boundaries.

The stakes of this microscopic operation become clear when it fails. In higher organisms such as mammals, flies and fungi, the genome is enclosed in a nucleus bounded by a nuclear envelope of two stacked membranes. Nuclear pores are the only conduits through the envelope, and each one must be assembled by fusing the inner and outer membranes at a single point. If fusion stalls, pore assembly stalls with it, and the vital traffic of proteins and RNA between nucleus and cytoplasm is compromised. Cells that cannot build their pores cannot survive, which is why the machinery described in the new papers is so critical, and why mutations that impair it produce disease.

That disease is primary dystonia, specifically DYT1 dystonia, a rare and currently incurable neurological movement disorder that affects roughly six in every 100,000 people worldwide. The condition usually begins in childhood and manifests as painful muscle spasms and abnormal postures that can be severely disabling. Treatment options today are limited to alleviating symptoms, chiefly through physiotherapy or injections of botulinum toxin, and no therapy addresses the underlying cause. The new findings give that cause a molecular identity: in people with primary dystonia, a mutation in the Torsin1A gene prevents the Torsin1A molecule from functioning correctly, leaving the CLCC1 complex without sufficient support to carry out its membrane-fusion duties during nuclear pore assembly.

Crucially, the research also points toward a possible intervention. In experiments with fruit flies, the researchers showed that artificially increasing CLCC1 levels can correct defects that arise, for example, during germline cell development, even when Torsin-1A function is impaired. This suggests that the CLCC1 complex is the limiting factor in the fusion reaction, and that boosting its availability can compensate for a weakened partner enzyme. The result transforms a fundamental cell-biological discovery into a concrete therapeutic hypothesis: if the balance between Torsin1A and CLCC1 can be shifted in patients, the cellular defects that drive dystonia might be partially or fully corrected.

One lingering mystery is why the same Torsin1A mutation produces symptoms in only about a third of the people who carry it. The researchers speculate that person-specific differences in CLCC1 protein levels may contribute to this variable penetrance, meaning that individuals with naturally higher amounts of the fusion protein might be better buffered against the effects of the faulty enzyme. If that hypothesis holds up, measuring or modulating CLCC1 levels could become not only a treatment strategy but also a way to predict who is at risk. Ulrike Kutay noted that the finding helps the team envision a possible therapy, with one potential strategy being to boost CLCC1 production or to prevent the protein from being broken down inside cells. This approach has already shown success in human cell cultures and in fruit flies, although whether it can be translated to patients must first be evaluated in further clinical studies and drug screens.

Beyond the immediate therapeutic horizon, the work opens several new lines of inquiry. The teams plan to investigate additional relatives of Torsin1A; human cells contain other torsins whose precise functions remain unknown, and the tools and concepts developed in this study should now make those functions accessible to experiment. In collaboration with plant scientists, Kutay, Weis, Jagannathan and their colleagues also aim to determine whether similar molecules and fusion mechanisms operate in plants, which would indicate that the pathway is a universal feature of eukaryotic life. For the researchers, the journey from a basic question about how cells punch holes in their own nucleus to a candidate therapy for a devastating childhood disease is a powerful illustration of why curiosity-driven research matters. Fundamental discoveries about the smallest building blocks of life, they argue, remain the most reliable starting point for the medicines of tomorrow.

Subject of Research: Membrane fusion mechanism of nuclear pore complex assembly and its link to DYT1 dystonia

Article Title: How cells make their command center accessible

Article References: How cells make their command center accessible. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: nuclear pore complex, nuclear envelope, membrane fusion, Torsin-1A, CLCC1, DYT1 dystonia, ETH Zurich, Molecular Cell, cell biology, neurological disorder, gene mutation, basic research

The authors argue that the confusion surrounding translational research is not primarily conceptual but operational. Researchers widely accept that medical advances should arise from clinical needs and eventually return to clinical practice, but there has been no clear, actionable framework describing how an individual investigator, particularly one starting from scratch, should initiate and structure such a project. Yin and Wang, who are affiliated with the Engineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy and the Division of Hepatobiliary and Pancreatic Surgery at the Second Affiliated Hospital of Dalian Medical University, draw on their own accumulated experience to distill the translational process into a sequence of defined stages, each with a distinct purpose and output.

The proposed strategy begins not in the laboratory but in the clinic. According to the framework, the first step is active engagement in clinical practice accompanied by systematic study of clinical practice guidelines. This pairing is deliberate: daily patient care exposes clinicians to unresolved problems, uncertainties, and inefficiencies, while practice guidelines codify the current state of accepted knowledge and, crucially, reveal its boundaries. By reading guidelines critically, a researcher can identify where recommendations are weak, based on limited evidence, or silent on important questions. The intersection of bedside observation and guideline analysis is where the strategy locates the raw material of translational research: a well-defined clinical question rooted in genuine unmet need rather than in laboratory convenience or intellectual fashion.

Once a clinical question has been formulated, the second step is a comprehensive literature review focused specifically on that question. The purpose of this review is not the broad survey familiar from graduate coursework but a targeted search for potential solutions to the identified clinical problem. The authors emphasize that this stage serves a dual function: it prevents duplication of existing work and, more importantly, it allows the researcher to convert a clinical question into a scientific one. A clinical question asks what should be done for patients; a scientific question asks what mechanism, intervention, or biological principle might answer that need. The literature review is the bridge between the two, revealing which candidate approaches are plausible and which have already been exhausted.

The third step introduces empirical data into the pipeline. With a scientific question in hand, the researcher conducts preliminary clinical research designed to identify potential answers. These early studies are not expected to be definitive; rather, they function as exploratory probes that generate observations, signals, and patterns from real clinical material. The output of this stage is a scientific hypothesis, a testable proposition that could, if confirmed, resolve the original clinical question. This sequencing reflects a core principle of the translational philosophy articulated by the authors: hypotheses in medical research should emerge from clinical reality rather than being imported wholesale from basic science journals, ensuring that the eventual findings have a clear path back to patient care.

The fourth step returns to the literature, this time with a different objective. Having proposed a scientific hypothesis, the researcher must conduct a detailed review to assess the current research status of that hypothesis. This assessment determines whether the hypothesis is novel, partially explored, or already refuted, and it maps the technical landscape that any validation effort must navigate. In the authors’ framework, this second literature review is not redundant with the first; the first survey searched for solutions to a clinical problem, while the second interrogates the standing of a specific hypothesis within the scientific community. The distinction matters practically, because a promising hypothesis may fail at this stage if prior work has already settled the question, saving the researcher months or years of misdirected effort.

Only after these preparatory stages does the strategy reach its culmination: the sequential conduct of clinical research and basic research to validate the proposed hypothesis. The word sequential is significant. Rather than launching laboratory experiments in isolation, the framework prescribes an ordered interplay in which clinical observations guide laboratory investigation, and laboratory findings are in turn tested against clinical data. This iterative loop embodies the two directions of translational medicine, often described as bench-to-bedside and bedside-to-bench. The design ensures that every laboratory experiment has a clinical justification and that every clinical finding is pursued to its mechanistic roots, closing the conceptual gap that the authors identify as the field’s central weakness.

The significance of this contribution lies less in any single technical innovation than in its pedagogical clarity. Translational medicine has become a keyword in grant applications, institutional missions, and journal scopes, yet trainees frequently report that the term offers little guidance on day-to-day research decisions. By specifying five ordered steps, from clinical practice and guideline study, through literature review and hypothesis formation, to sequential validation, the strategy converts a broad principle into a tangible research plan. For early-career clinicians contemplating their first project, the framework provides an entry point that does not require prior laboratory expertise, deep funding, or access to advanced facilities, only disciplined attention to the questions their own patients generate.

The commentary also carries implications for how research institutions and mentors might structure training. If clinical questions are the proper starting point of medical research, then departments that separate clinical duties from research training may be systematically misallocating their talent. The authors’ experience in hepatobiliary and pancreatic surgery and in translational medicine engineering suggests that surgical specialties, where unmet needs are encountered daily, are particularly fertile ground for this approach. Institutions could, in principle, embed guideline-reading exercises, structured literature reviews, and preliminary clinical data collection into residency and fellowship programs, producing a pipeline of investigators whose research agendas are anchored in clinical relevance from the outset.

Like any framework distilled from individual experience, the strategy will require testing and refinement across specialties, disease areas, and research cultures, and the authors present it as a proposal rather than a proven protocol. Nevertheless, its publication in an open-access venue means that the full stepwise approach is freely available to the global research community, from well-funded academic centers to resource-limited hospitals in developing regions. At a time when the volume of biomedical literature grows faster than any individual’s capacity to absorb it, a clear, question-driven roadmap for turning clinical puzzles into validated scientific knowledge offers something genuinely valuable: a way for the next generation of medical researchers to begin, and a reminder that the most important research questions are often standing in the clinic all along, waiting to be asked.

Subject of Research: A clinical question-driven step-by-step strategy for conducting translational medical research

Article Title: How to conduct medical research: a clinical question-driven step-by-step medical research strategy based on the concept of translational medicine

Article References: Yin, Z., & Wang, L. (2026). How to conduct medical research: a clinical question-driven step-by-step medical research strategy based on the concept of translational medicine. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-08943-z

Image Credits: AI Generated

DOI: 10.1186/s12967-026-08943-z

Keywords: translational medicine, medical research, clinical questions, research strategy, clinical practice guidelines, scientific hypothesis, literature review, clinical research, basic research, bench to bedside, research training, Journal of Translational Medicine